SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-034591
Filing Date
2021-06-25
Accepted
2021-06-25 16:15:57
Documents
12
Period of Report
2021-06-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K kura-8k_20210622.htm   iXBRL 8-K 74494
  Complete submission text file 0001564590-21-034591.txt   205225

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kura-20210622.xsd EX-101.SCH 5792
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20210622_lab.xml EX-101.LAB 19469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20210622_pre.xml EX-101.PRE 11642
5 EXTRACTED XBRL INSTANCE DOCUMENT kura-8k_20210622_htm.xml XML 3559
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 211047963
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences